Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin loading or priming in HCV genotype 1
NCT01226771Phase 3Completed
- Sponsor
- University of Gothenburg
- Start
- Sep 2010
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ribavirin in chronic hepatitis C virus infection, sponsored by University of Gothenburg. Started Sep 2010; status: completed.
02
Drugs
ribavirin
03
Conditions
chronic hepatitis C virus infection
Beyond the preview
Go deeper on NCT01226771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226771.